• OPEN AN ACCOUNT
Indian Indices
Nifty
24,631.30 11.95
(0.05%)
Sensex
80,597.66 57.75
( 0.07%)
Bank Nifty
55,341.85 160.40
( 0.29%)
Nifty IT
34,833.20 140.25
( 0.40%)
Global Indices
Nasdaq
44,924.55 -18.73
(-0.04%)
Dow Jones
6,489.27 1.69
(0.03%)
Hang Seng
43,330.92 681.66
(1.60%)
Nikkei 225
9,177.24 12.01
(0.13%)
Forex
USD-INR
87.51 -0.12
(-0.14%)
EUR-INR
102.40 0.39
(0.38%)
GBP-INR
118.57 0.53
(0.45%)
JPY-INR
0.59 0.00
(0.27%)

EQUITY - MARKET SCREENER

Bharat Immunological & Biological Corporation Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524663
INE994B01014
-7.5352246
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
95.38
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

bajaj finance ltd
Indian Bank’s total deposits climb 9% YoY to Rs 7.44 lakh crore in Q1
Jul 03,2025
On a sequential basis, the bank’s deposits increased 0.95% from Rs 7.37 lakh crore as of 31st March 2025.

Total business jumped 10.2% YoY and 1.43% QoQ to Rs 13.44 lakh crore as of 30 June 2025.

Gross advances stood at Rs 6 lakh crore as of 30 June 2025, registering the growth of 11.3% YoY and 2.04% QoQ.

Indian Bank is a medium-sized public sector bank offering a wide range of financial products and services, including deposits and loans. Its key business segments comprise Treasury, Corporate/Wholesale Banking, Retail Banking, and Other Banking Operations.

The bank’s net profit jumped 31.56% to Rs 2,956.07 crore on a 10.14% increase in total income to Rs 18,599.16 crore in Q4 FY25 over Q4 FY24.

The scrip fell 0.65% to end at Rs 545.70 on Friday, 4 April 2025.